已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Primary site surgery of de novo stage IV HER2-positive breast cancer in the era of new drug treatments

医学 乳腺癌 背景(考古学) 癌症 阶段(地层学) 回顾性队列研究 转移性乳腺癌 单变量分析 外科 内科学 原发性肿瘤 病态的 肿瘤科 乳房外科 多元分析 比例危险模型 转移 古生物学 生物
作者
Guanyu Lu,Lin Jia,Ruohan Yang,Yutong Liu,Zheng Lv,Jiuwei Cui
出处
期刊:Frontiers in Oncology [Frontiers Media]
卷期号:13: 1308854-1308854 被引量:4
标识
DOI:10.3389/fonc.2023.1308854
摘要

Objective The surgical treatment of the primary site has been a subject of controversy in patients with de novo metastatic breast cancer. In recent years, studies using large databases and retrospective analyses have provided evidence of the survival benefits of localized surgery for these patients. However, due to the improved prognosis associated with novel antitumor agents and the widespread use of anti-HER2 therapy, it is important to investigate the role of primary site surgery in the context of new drug treatments for stage IV HER2-positive breast cancer. Methods This retrospective analysis included patients with metastatic breast cancer at diagnosis who were consulted at the First Hospital of Jilin University between 2016 and 2022. We compared the patients’ clinical and pathological characteristics, treatment regimens, and prognosis between the surgery and non-surgery groups. Results A total of 96 patients with stage IV HER2-positive breast cancer were included in the study, with 24 patients (25%) undergoing surgery for the primary lesion. Patients with lower Eastern Cooperative Oncology Group (ECOG) scores, earlier T-stage, metastases confined to one organ/site, and fewer metastases were more likely to undergo surgery. Patients in the surgical group had longer progression-free survival (median 25.7 vs. 15.9 months, p=0.073) and overall survival (median 79.1 vs. 48 months, p=0.073) compared to patients in the non-surgical group, however, there was no statistical difference. Univariate and multivariate Cox regression analysis suggested that the choice of first-line targeted therapy regimens rather than surgical treatment influenced the patients’ prognoses. In the subgroup of patients receiving first-line targeted therapy with trastuzumab plus pertuzumab, the decision to undergo surgery on the primary site did not have a statistically significant effect on prognosis. Conclusion Primary site surgery does not improve the prognosis of de novo stage IV HER2-positive breast cancer. In the era of anti-HER2 therapy, primary surgery is not recommended, except in exceptional circumstances.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
ww完成签到 ,获得积分10
1秒前
长情的雨发布了新的文献求助10
1秒前
White发布了新的文献求助20
2秒前
369ninja发布了新的文献求助10
4秒前
徐豆芽发布了新的文献求助10
4秒前
贪玩飞珍完成签到,获得积分10
6秒前
章鱼发布了新的文献求助10
6秒前
8秒前
虚拟的如容完成签到,获得积分10
8秒前
9秒前
11秒前
miumiu2024发布了新的文献求助10
11秒前
丘比特的应助被EstAffectus采纳,获得30
11秒前
dopamine发布了新的文献求助10
12秒前
极限001的应助被科研通管家采纳,获得100
12秒前
12秒前
Jasper的应助被科研通管家采纳,获得10
12秒前
华仔的应助被科研通管家采纳,获得10
13秒前
13秒前
共享精神的应助被科研通管家采纳,获得100
13秒前
13秒前
脑洞疼的应助被科研通管家采纳,获得10
13秒前
13秒前
隐形曼青的应助被科研通管家采纳,获得10
13秒前
SZL2026发布了新的文献求助20
13秒前
天天快乐的应助被科研通管家采纳,获得100
13秒前
13秒前
赘婿的应助被科研通管家采纳,获得10
14秒前
深情安青的应助被科研通管家采纳,获得100
14秒前
orixero的应助被科研通管家采纳,获得10
14秒前
烟花的应助被科研通管家采纳,获得10
14秒前
上官若男的应助被科研通管家采纳,获得10
14秒前
14秒前
俊逸盛男发布了新的文献求助10
14秒前
伸懒腰发布了新的文献求助10
14秒前
丘比特的应助被swimming采纳,获得10
14秒前
彭于晏的应助被科研通管家采纳,获得10
14秒前
秋风的应助被monster采纳,获得10
15秒前
lllcy发布了新的文献求助10
16秒前
Lily发布了新的文献求助10
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8184536
求助须知:如何正确求助?哪些是违规求助? 9573526
关于积分的说明 21832132
捐赠科研通 7781791
什么是DOI,文献DOI怎么找? 3434376
关于科研通互助平台的介绍 2558490
邀请新用户注册赠送积分活动 2480989